| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PNAS..11212516S |
| P356 | DOI | 10.1073/PNAS.1516645112 |
| P932 | PMC publication ID | 4603492 |
| P698 | PubMed publication ID | 26392547 |
| P5875 | ResearchGate publication ID | 282051964 |
| P50 | author | Michael P Schwartz | Q56424193 |
| Vítor Santos Costa | Q45892748 | ||
| P2093 | author name string | Ron Stewart | |
| Yu Wang | |||
| Peng Jiang | |||
| James A Thomson | |||
| C David Page | |||
| Jue Zhang | |||
| William L Murphy | |||
| Nicholas E Propson | |||
| Zhonggang Hou | |||
| Jennifer M Bolin | |||
| Bao Kim Nguyen | |||
| Collin J Engstrom | |||
| William Daly | |||
| P2860 | cites work | Development and evolution of the human neocortex | Q22337363 |
| Gene ontology: tool for the unification of biology | Q23781406 | ||
| Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization | Q26852191 | ||
| Neurobehavioural effects of developmental toxicity | Q26998967 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models | Q29547388 | ||
| Physiology of microglia | Q29547414 | ||
| An anatomically comprehensive atlas of the adult human brain transcriptome | Q29614949 | ||
| Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism | Q29615446 | ||
| Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 | ||
| Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
| Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule | Q29616413 | ||
| The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease | Q30466613 | ||
| A mesoderm-derived precursor for mesenchymal stem and endothelial cells | Q30498095 | ||
| Evaluation of multiple models to distinguish closely related forms of disease using DNA microarray data: an application to multiple myeloma | Q31038561 | ||
| Support vector machine classification and validation of cancer tissue samples using microarray expression data | Q31835844 | ||
| Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia | Q33383369 | ||
| Concordance of the toxicity of pharmaceuticals in humans and in animals | Q33921168 | ||
| Early development and composition of the human primordial plexiform layer: An immunohistochemical study | Q48140298 | ||
| The first neurons of the human cerebral cortex. | Q48493632 | ||
| Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin | Q78842318 | ||
| Specific characteristic of radial glia in the human fetal telencephalon | Q80486121 | ||
| Transcriptional landscape of the prenatal human brain | Q33926910 | ||
| Matrigel: a complex protein mixture required for optimal growth of cell culture. | Q34021289 | ||
| Lead neurotoxicity in children: basic mechanisms and clinical correlates | Q34164058 | ||
| Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport | Q34322448 | ||
| Clinical development success rates for investigational drugs | Q34396786 | ||
| Organogenesis in a dish: modeling development and disease using organoid technologies | Q34429586 | ||
| Elevated oleic acid serum concentrations in patients suffering from alcohol dependence | Q34470915 | ||
| Biomaterial arrays with defined adhesion ligand densities and matrix stiffness identify distinct phenotypes for tumorigenic and nontumorigenic human mesenchymal cell types. | Q34470958 | ||
| A Versatile Synthetic Extracellular Matrix Mimic via Thiol-Norbornene Photopolymerization | Q34481188 | ||
| Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions | Q34684059 | ||
| A quantitative framework to evaluate modeling of cortical development by neural stem cells | Q34775670 | ||
| The corticofugal neuron-associated genes ROBO1, SRGAP1, and CTIP2 exhibit an anterior to posterior gradient of expression in early fetal human neocortex development. | Q34992405 | ||
| International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes | Q35024730 | ||
| A cost-effective RNA sequencing protocol for large-scale gene expression studies | Q35238529 | ||
| Neuronal action on the developing blood vessel pattern | Q35592822 | ||
| The importance of microglia in the development of the vasculature in the central nervous system | Q36643118 | ||
| In vitro perfused human capillary networks | Q37035799 | ||
| Development of the human cerebral cortex: Boulder Committee revisited | Q37061975 | ||
| Mechanisms of neural specification from embryonic stem cells | Q37676542 | ||
| Early microglial colonization of the human forebrain and possible involvement in periventricular white-matter injury of preterm infants | Q37765920 | ||
| Self-formation of layered neural structures in three-dimensional culture of ES cells | Q37992359 | ||
| In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme | Q38200703 | ||
| Organs-on-chips (microphysiological systems): tools to expedite efficacy and toxicity testing in human tissue | Q38222998 | ||
| Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach | Q38319756 | ||
| Perfused multiwell plate for 3D liver tissue engineering | Q38590052 | ||
| EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments | Q39190922 | ||
| An optimized gene set for transcriptomics based neurodevelopmental toxicity prediction in the neural embryonic stem cell test | Q39320450 | ||
| Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals. | Q39594231 | ||
| Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides | Q41079349 | ||
| The human brain intracerebral microvascular system: development and structure | Q41816695 | ||
| In vitro differentiation of transplantable neural precursors from human embryonic stem cells | Q43814659 | ||
| Don't judge a neuron only by its cover: neuronal function in in vitro developmental neurotoxicity testing. | Q44431769 | ||
| Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures | Q48113650 | ||
| Oleic acid synthesized in the periventricular zone promotes axonogenesis in the striatum during brain development. | Q48129802 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | RNA sequencing | Q2542347 |
| pluripotency | Q1894941 | ||
| P304 | page(s) | 12516-12521 | |
| P577 | publication date | 2015-09-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Human pluripotent stem cell-derived neural constructs for predicting neural toxicity | |
| P478 | volume | 112 |
| Q45913223 | 3-D Bioprinting of Neural Tissue for Applications in Cell Therapy and Drug Screening. |
| Q41463305 | 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders |
| Q90501972 | 3D-cultured neural stem cell microarrays on a micropillar chip for high-throughput developmental neurotoxicology |
| Q38710474 | A Genome-wide Analysis of Human Pluripotent Stem Cell-Derived Endothelial Cells in 2D or 3D Culture. |
| Q33796396 | A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response |
| Q90453239 | A high-throughput imaging and nuclear segmentation analysis protocol for cleared 3D culture models |
| Q37367253 | A statistical approach for identifying differential distributions in single-cell RNA-seq experiments |
| Q39320908 | Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity |
| Q58799132 | An Overview of Methods to Study Microglia |
| Q88368594 | An in vivo model of functional and vascularized human brain organoids |
| Q97516713 | Application of Fused Organoid Models to Study Human Brain Development and Neural Disorders |
| Q63246144 | Assembly of Human Stem Cell-Derived Cortical Spheroids and Vascular Spheroids to Model 3-D Brain-like Tissues |
| Q38637370 | Bioengineering solutions for manufacturing challenges in CAR T cells. |
| Q90237406 | BrainImageR: spatiotemporal gene set analysis referencing the human brain |
| Q97535454 | CRISPR-based functional genomics for neurological disease |
| Q92824153 | CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation |
| Q47711481 | Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms |
| Q91885689 | Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia |
| Q36717285 | Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders |
| Q39367071 | Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells |
| Q38895704 | Developments in 3D neural cell culture models: the future of neurotherapeutics testing? |
| Q92988149 | Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids |
| Q64963223 | Differentiation and Functional Comparison of Monocytes and Macrophages from hiPSCs with Peripheral Blood Derivatives. |
| Q39375830 | Drug discovery for remyelination and treatment of MS. |
| Q57142500 | Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons |
| Q90404011 | Engineering tissue-specific blood vessels |
| Q38940313 | Evolution to the rescue: using comparative genomics to understand long non-coding RNAs |
| Q47137884 | Frontiers in Toxicogenomics in the Twenty-First Century-the Grand Challenge: To Understand How the Genome and Epigenome Interact with the Toxic Environment at the Single-Cell, Whole-Organism, and Multi-Generational Level |
| Q38697573 | Functional characterization of human pluripotent stem cell-derived arterial endothelial cells |
| Q66678798 | Functionalization of Brain Region-specific Spheroids with Isogenic Microglia-like Cells |
| Q92763088 | Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology |
| Q51418353 | High-content imaging assays on a miniaturized 3D cell culture platform. |
| Q38700102 | Human Induced Pluripotent Stem Cell-Derived Endothelial Cells for Three-Dimensional Microphysiological Systems |
| Q51416081 | Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development. |
| Q38753758 | In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities |
| Q90482216 | In vitro and computational modelling of drug delivery across the outer blood-retinal barrier |
| Q26738711 | In vitro models of medulloblastoma: Choosing the right tool for the job |
| Q39040578 | Induced pluripotent stem cell technology: a decade of progress |
| Q51417311 | Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies. |
| Q58789313 | Machine Learning Based Toxicity Prediction: From Chemical Structural Description to Transcriptome Analysis |
| Q90385482 | Machine learning to predict developmental neurotoxicity with high-throughput data from 2D bio-engineered tissues |
| Q33891569 | Microphysiological Systems ("Organs-on-Chips") for Drug Efficacy and Toxicity Testing |
| Q47795944 | Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research |
| Q38666481 | Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells |
| Q55231889 | Modeling Neurological Diseases With Human Brain Organoids. |
| Q52431644 | Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells. |
| Q49601349 | Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells. |
| Q93038643 | Modeling genetic epilepsies in a dish |
| Q38690794 | Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem Cells |
| Q38962283 | Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets |
| Q46088748 | Neural Differentiation of Spheroids Derived from HiPSC-MSC Co-Culture |
| Q49569055 | Organoid and Organ-On-A-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease. |
| Q46310313 | Organoid technology for brain and therapeutics research |
| Q47884911 | Organoids required! A new path to understanding human brain development and disease |
| Q63740160 | Organs to Cells and Cells to Organoids: The Evolution of Central Nervous System Modelling |
| Q38739678 | Organs-on-chips: Progress, challenges, and future directions |
| Q99350419 | Organs-on-chips: into the next decade |
| Q90114559 | PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia |
| Q47196503 | Pathology, proteomics and the pathway to personalised medicine. |
| Q38786566 | Patient-derived induced pluripotent stem cells in cancer research and precision oncology. |
| Q38704159 | Programming microphysiological systems for children's health protection |
| Q42603119 | Prospects and Frontiers of Stem Cell Toxicology |
| Q90631755 | Quantitative Label-Free Imaging of 3D Vascular Networks Self-Assembled in Synthetic Hydrogels |
| Q90662510 | Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy |
| Q50421707 | Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity. |
| Q91677951 | Recursive Feature Elimination by Sensitivity Testing |
| Q38862587 | Review: Induced pluripotent stem cell models of frontotemporal dementia |
| Q37185635 | Single-cell RNA-seq reveals novel regulators of human embryonic stem cell differentiation to definitive endoderm |
| Q36792141 | Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels |
| Q57345687 | Stem Cells, Bioengineering, and 3-D Scaffolds for Nervous System Repair and Regeneration |
| Q38860848 | Synthetic hydrogels mimicking basement membrane matrices to promote cell-matrix interactions. |
| Q57156286 | Teratogen screening with human pluripotent stem cells |
| Q55710828 | The Role of Biomaterials in Implantation for Central Nervous System Injury. |
| Q57491536 | The Use of Stem Cell-Derived Neurons for Understanding Development and Disease of the Cerebellum |
| Q38802467 | The promises and challenges of human brain organoids as models of neuropsychiatric disease |
| Q47842599 | The rise of three-dimensional human brain cultures |
| Q92460525 | The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis |
| Q38734115 | The use of human neurons for novel drug discovery in dementia research. |
| Q47670436 | The utility of stem cells in pediatric urinary bladder regeneration |
| Q88098314 | Three-Dimensional Cell Cultures in Drug Discovery and Development |
| Q92833446 | Three-dimensional modeling of human neurodegeneration: brain organoids coming of age |
| Q38926188 | Tissue Chips to aid drug development and modeling for rare diseases |
| Q38644609 | Tissue chips - innovative tools for drug development and disease modeling. |
| Q52795421 | Toward modeling the human nervous system in a dish: recent progress and outstanding challenges. |
| Q37356503 | Translating Stem Cell Biology Into Drug Discovery |
| Q50260523 | Translational potential of human brain organoids. |
| Q46344752 | Uniform neural tissue models produced on synthetic hydrogels using standard culture techniques. |
| Q89833307 | Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion |
| Q28973608 | Wnt-YAP interactions in the neural fate of human pluripotent stem cells and the implications for neural organoid formation |
| Q47307855 | Wnt/Yes-Associated Protein Interactions During Neural Tissue Patterning of Human Induced Pluripotent Stem Cells |
| Q47107565 | YAP-dependent mechanotransduction is required for proliferation and migration on native-like substrate topography |
Search more.